Good Jennifer L

President & CEO, DirectorTrevi Therapeutics, Inc. (TRVI) · full profile →Form 4 · filed Sep 5, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$170K
Net Open-Market Flow
-$170K
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 5, 2024Sell(S)40K$3.11$125K213K
Sep 5, 2024Option exercise(M)40K$1.43$58K254K
Sep 4, 2024Sell(S)11K$3.02$33K213K
Sep 4, 2024Option exercise(M)11K$1.43$16K224K
Sep 3, 2024Sell(S)4K$3.02$12K213K
Sep 3, 2024Option exercise(M)4K$1.43$6K217K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 5, 2024Option exercise(M)40K$06K
Sep 4, 2024Option exercise(M)11K$046K
Sep 3, 2024Option exercise(M)4K$057K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-104061) within minutes of acceptance. Every field above traces to the original document. Verify it directly: